As Alexion, AstraZeneca Rare Disease, we are delivering life-changing therapies to people living with rare diseases.

As Alexion, AstraZeneca Rare Disease, we are delivering life-changing therapies to people living with rare diseases. Our Mission To transform the lives of people affected by rare diseases and devastating conditions by continuously innovating and creating meaningful value in all that we do.

This website is intended for people seeking information on Alexion, AstraZeneca Rare Disease’s worldwide business. Veeva ID: GL/ALL/0071 Date of preparation: January 2025 About Alexion

This website is intended for people seeking information on Alexion, AstraZeneca Rare Disease’s worldwide business. Veeva ID: GL/ALL/0071 Date of preparation: January 2025

Alexion’s rich history of scientific firsts has accelerated the course of rare disease R&D and changed the trajectory of treatment for people living with certain rare conditions.

At Alexion, our mission is to transform the lives of people with rare diseases through the development and delivery of innovative medicines, as well as support technologies and healthcare services. For over three decades, patients and their caregivers have been at the centre of everything we do.

Alexion has more than 5,000 employees around the globe and serves patients in more than 50 countries. There are limitless opportunities for talented individuals to work across functions and geographies, taking on new challenges to support healthcare services and transform the lives of people affected by rare diseases.

Jun 8, 2024 · Getting to know Adrian Kielhorn, an Alexion R&D Leading Voice. Alexion’s leadership in rare disease is driven by the many individuals whose expertise, creativity and tenacity fuel our commitment to advancing innovative science.

Through partnerships, scientific collaborations and clinical trial investments, Alexion Canada is leading the way to transform the lives of people affected by rare diseases – one patient at a time. Medicines

Dal 2019, Alexion ha condotto in Italia più di 36 studi clinici; quelli attivi nel corso del 2024 sono stati 22 in 150 centri, per un totale di oltre 200 pazienti coinvolti. Le nostre aree terapeutiche